Ocugen, Inc. (OCGN)
1.365
-0.02
(-1.80%)
USD |
NASDAQ |
Aug 24, 16:00
1.36
0.00 (0.00%)
After-Hours: 20:00
Ocugen Total Liabilities (Quarterly) : 140.76M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 140.76M |
| March 31, 2026 | 51.10M |
| December 31, 2025 | 56.46M |
| September 30, 2025 | 54.06M |
| June 30, 2025 | 50.54M |
| March 31, 2025 | 48.55M |
| December 31, 2024 | 53.71M |
| September 30, 2024 | 21.31M |
| June 30, 2024 | 23.62M |
| March 31, 2024 | 21.53M |
| December 31, 2023 | 24.90M |
| September 30, 2023 | 16.29M |
| June 30, 2023 | 18.70M |
| March 31, 2023 | 20.50M |
| December 31, 2022 | 35.63M |
| September 30, 2022 | 20.94M |
| June 30, 2022 | 15.98M |
| March 31, 2022 | 10.60M |
| December 31, 2021 | 9.943M |
| September 30, 2021 | 9.202M |
| June 30, 2021 | 7.842M |
| March 31, 2021 | 7.358M |
| December 31, 2020 | 5.826M |
| September 30, 2020 | 6.118M |
| June 30, 2020 | 9.136M |
| Date | Value |
|---|---|
| March 31, 2020 | 5.017M |
| December 31, 2019 | 5.789M |
| September 30, 2019 | 36.71M |
| June 30, 2019 | 11.93M |
| March 31, 2019 | 20.37M |
| December 31, 2018 | 15.16M |
| September 30, 2018 | 20.56M |
| June 30, 2018 | 38.59M |
| March 31, 2018 | 41.40M |
| December 31, 2017 | 22.30M |
| September 30, 2017 | 20.64M |
| June 30, 2017 | 21.32M |
| March 31, 2017 | 21.34M |
| December 31, 2016 | 22.51M |
| September 30, 2016 | 38.76M |
| June 30, 2016 | 8.389M |
| March 31, 2016 | 7.923M |
| December 31, 2015 | 8.588M |
| September 30, 2015 | 9.125M |
| June 30, 2015 | 9.373M |
| March 31, 2015 | 10.36M |
| December 31, 2014 | 11.29M |
| September 30, 2014 | 43.44M |
| June 30, 2014 | 34.54M |
| March 31, 2014 | 31.82M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| CytomX Therapeutics, Inc. | 79.16M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Biogen, Inc. | 13.24B |
| Gilead Sciences, Inc. | 37.62B |
| MannKind Corp. | 799.50M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 124.21M |
| Shareholders Equity (Quarterly) | -16.56M |
| Debt to Equity Ratio | -5.314 |
| Current Ratio | 0.8019 |
| Net Debt Paydown Yield | -2.17% |